Computer game helps COPD patients breathe betterApril 15, 2008Patients with chronic obstructive pulmonary disease (COPD) may gain better control over their breathing and breathe more efficiently by using their breath to play a computer game, according to new research. "COPD is a double-edged sword: the incapacitating lung condition can cause such serious shortness of breath that every-day physical activity, such as walking a flight of stairs, becomes unduly burdensome-and yet one of the few effective symptomatic treatments for COPD is the very thing that its victims dread most: exercise," said leading researcher Eileen G. Collins, Ph.D., of the Edward Hines Jr. VA Hospital in Hines, Illinois and UIC. "This computerized program is still in the research stages, but shows promise for future use in pulmonary rehabilitation programs." The results of this randomized, controlled study appeared in the April 15 issue of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.
COPD patients with the greatest disability are also those most likely to be unable to exercise long enough to reap the benefits rehabilitation can offer them. "One of the key mechanisms of shortness of breath and exercise impairment in these patients," Dr. Collins said, "is their inability to fully exhale air when active." This phenomenon causes trapping of air in the lungs-i.e., dynamic hyperinflation-and diminishes the patient's breathing efficiency. Dr. Collins and colleagues designed a randomized, controlled trial, the first of its kind, to test whether this computer program could decrease the extent of air trapping during exercise and thus improve the results of rehabilitation in COPD patients. "Our primary goal was to determine if patients with COPD would achieve longer exercise duration if they were engaged in ventilation feedback, in addition to the regular exercise program over either ventilation feedback or exercise alone," said Dr. Collins. A total of 64 patients were randomized to three groups- exercise alone, exercise plus ventilation feedback (VF) or VF alone. VF patients had their breathing monitored by a computer program which provided them with real-time biofeedback and set individualized goals, presented graphically on a screen in front of them. Patients could see their current speed and depth of breathing in relation to the set goal, encouraging them to inhale more slowly and exhale more completely in order to achieve the goal. At baseline, the groups all performed similarly in exercise tolerance tests. Comparing all the groups, those that underwent a regimen of exercise and ventilation feedback showed significant improvements in exercise duration, and those who underwent exercise alone fared much better than those who only received ventilation feedback. Because of the multiple comparisons between groups, the exercise-plus-ventilation feedback group did not attain statistically significant improvements over the exercise-only group, but the results indicated a strong trend in that direction. Exercise-induced hyperinflation was also reduced in patients randomized to exercise-plus-ventilation feedback over either program by itself. Duration of exercise tolerance in the exercise-plus-ventilation feedback group also showed a significant trend toward improvement. If patients can be taught to translate these breathing techniques from the computer game to activities of daily living, they could potentially greatly improve their quality of life. "We are conducting a follow-up clinical trial to compare computerized breathing feedback with other unique methods of pulmonary rehabilitation," said Dr. Collins. American Thoracic Society | |||||||||||||||||||||
|
Related Chronic Obstructive Pulmonary Disease News Articles Flu shot does not reduce risk of death The widely-held perception that the influenza vaccination reduces overall mortality risk in the elderly does not withstand careful scrutiny, according to researchers in Alberta. Infection Blocks Lung's Protective Response Against Tobacco Smoke An infection that often goes undetected can block the lung's natural protective response against tobacco smoke, according to researchers at National Jewish Health. Hope for patients with COPD For the first time, a drug therapy appears to reduce lung function loss in patients with moderate to severe chronic obstructive pulmonary disease (COPD), according to the results of a randomized, double-blind, placebo-controlled trial in 42 countries. Yale study shows why cigarette smoke makes flu, other viral infections worse A new study by researchers at Yale School of Medicine could explain why the cold and flu virus symptoms that are often mild and transient in non-smokers can seriously sicken smokers. Published in the Journal of Clinical Investigation, the study also identified the mechanism by which viruses and cigarette smoke interact to increase lung inflammation and damage. Smoking out the mediators of airway damage caused by pollutants New insight into how pollution and cigarette smoke damage airways has been provided by Pierangelo Geppetti and colleagues, at the University of Florence, Italy, who studied the effects of such chemicals on guinea pig airways. Brief, intense exercise benefits the heart Short bursts of high intensity sprints-known to benefit muscle and improve exercise performance-can improve the function and structure of blood vessels, in particular arteries that deliver blood to our muscles and heart, according to new research from McMaster University. Low-intensity case management cuts COPD-related hospital visits in half A new study has found that patients with chronic obstructive pulmonary disease (COPD) who are at high risk for hospitalization or emergency room visits from exacerbations or complications benefit from simple low-intensity case management. COPD patients benefit more from pulmonary rehab in earlier stages Patients with chronic obstructive pulmonary disease (COPD) who are in their final years of survival do not get the same benefits from pulmonary rehabilitation (PR) as patients who have more years left to live-regardless of their age, complicating illnesses or lung function. Personalized therapy for asthma and COPD could soon be here Researchers at Washington University School of Medicine in St. Louis have defined a new type of immune response that is activated in patients with severe asthma and COPD (chronic obstructive pulmonary disease). Their discovery could dramatically improve diagnosis and treatment of patients with chronic inflammatory lung disease. Biomarkers identified for idiopathic pulmonary fibrosis The first evidence of a distinctive protein signature that could help to transform the diagnosis and improve the monitoring of the devastating lung disease idiopathic pulmonary fibrosis (IPF) is being reported by University of Pittsburgh School of Medicine researchers in this month's edition of PLoS Medicine, an open-access journal of the Public Library of Science. More Chronic Obstructive Pulmonary Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||